Jee SH, Ohrr H, Sull JW, et al. Fasting serum glucose level and cancer risk in Korean men and women[J]. JAMA, 2005, 293(2): 194-202.
[2]
Stattin P, Bj?r O, Ferrari P, et al. Prospective study of hyperglycemia and cancer risk[J]. Diabetes Care, 2007, 30(3): 561-567.
[3]
Yamagata H, Kiyohara Y, Nakamura S, et al. Impact of fasting plasma glucose levels on gastric cancer incidence in a general Japanese population: the hisayama study[J]. Diabetes Care, 2005, 28(4): 789-794.
[4]
Bowker SL, Majumdar SR, Veuqelers P, et al. Increased cancer-related mortality for patients with type 2 diabetes who use sulfonylureas or insulin[J]. Diabetes Care, 2006, 29(2): 254-258.
[5]
Nassar AA, Boyle ME, Seifert KM, et al. Insulin pump therapy in patients with diabetes undergoing surgery[J]. Endocr Pract, 2011, 29: 1-22.
Samsom M, Bharucha A, Gerich JE, et al. Diabetes mellitus and gastric emptying:questions and issues in clinical practice[J]. Diabetes Metab Res Rev, 2009, 25(6): 502-514.